Safety and effectiveness of peanut oral immunotherapy in children under 12 months

J Allergy Clin Immunol Pract. 2023 Nov;11(11):3544-3546.e1. doi: 10.1016/j.jaip.2023.07.009. Epub 2023 Jul 14.

Authors

Sarah R Johnson¹, Kara McNamara², Jaclyn Bjelac², Leigh Ann Kerns², Ahila Subramanian², Alice E W Hoyt³, Rachel Whitsel², Sandra J Hong⁴

Affiliations

¹ Department of Allergy and Clinical Immunology, Cleveland Clinic Foundation, Cleveland, Ohio.
² Food Allergy Center of Excellence, Cleveland Clinic Foundation, Cleveland, Ohio.
³ Hoyt Institute of Food Allergy, New Orleans, La.
⁴ Food Allergy Center of Excellence, Cleveland Clinic Foundation, Cleveland, Ohio. Electronic address: hongs3@ccf.org.

PMID: 37453570
DOI: 10.1016/j.jaip.2023.07.009

No abstract available

MeSH terms

Administration, Oral
Allergens / therapeutic use
Arachis*
Child
Desensitization, Immunologic
Humans
Immunotherapy
Peanut Hypersensitivity* / therapy

Substances

Allergens